跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Piptacare - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Piptacare
Approved
STANDARD
Piptacare
CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
b193eddb2c86fb73
Company
CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd.
Type
Standard
Approval Details
Approval Id
b193eddb2c86fb73
Drug Approval Philippines Name
Piptacare
Product Name
Piptacare
Registration Number
DRP-3555-04
Brand Name
Piptacare
Generic Name
Piperacillin (as sodium) + Tazobactam (as sodium)
Dosage Form
Powder For Injection (Iv)
Dosage Strength
4g/500mg
Manufacturer
CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd.
Importer
amb hk enterprises, inc.
Distributor
icare pharmaceutical philippines incorporated
Company Detail Path
/organization/cspc-zhongnuo-pharmaceutical-shijiazhuang-co-ltd
Issuance Date
25 July 2024
Expiry Date
26 August 2029
Pharmacologic Category
Antibacterial
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
b193eddb2c86fb73
Type
Standard
Back to Philippines FDA Approvals